NANCY L OTT

Allopathic & Osteopathic Physicians|Allergy & Immunology MINNEAPOLIS, MN NPI 1295840783

General Payments — all program years on this page

$25,434.01

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 99
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $9,820.27 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $2,774.3911
2019 $439.638
2020 $78.285
2021 $229.5513
2022 $4,279.2420
2023 $7,812.6524
2024 $9,820.2718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104643359 AstraZeneca Pharmaceuticals LP $14.33 08/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116218422 GlaxoSmithKline, LLC. $117.18 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116277544 GlaxoSmithKline, LLC. $20.84 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116278352 GlaxoSmithKline, LLC. $1,625.00 08/08/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1116307289 GlaxoSmithKline, LLC. $18.35 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116407497 GlaxoSmithKline, LLC. $3,900.00 04/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1116734952 GlaxoSmithKline, LLC. $3,900.00 10/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1117475670 BioCryst US Sales Co., LLC $17.57 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117953793 Boehringer Ingelheim Pharmaceuticals, Inc. $16.28 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132159577 Pharming Healthcare, Inc. $16.46 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133077916 Genentech USA, Inc. $15.66 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599109 CSL Behring $24.00 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137646958 Takeda Pharmaceuticals U.S.A., Inc. $13.52 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139592710 GENZYME CORPORATION $15.68 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141180728 Incyte Corporation $16.66 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141181042 Incyte Corporation $24.51 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147454265 Blueprint Medicines Corporation $48.01 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152645221 LEO Pharma Inc. $16.22 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.